Thrivent Financial for Lutherans Buys 319,309 Shares of Kenvue Inc. $KVUE

Thrivent Financial for Lutherans raised its stake in shares of Kenvue Inc. (NYSE:KVUE) by 7.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,654,129 shares of the company’s stock after buying an additional 319,309 shares during the quarter. Thrivent Financial for Lutherans owned about 0.24% of Kenvue worth $75,536,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Salomon & Ludwin LLC bought a new position in shares of Kenvue during the third quarter worth $25,000. NBT Bank N A NY raised its stake in Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after buying an additional 1,006 shares during the period. Golden State Wealth Management LLC lifted its holdings in Kenvue by 150.1% during the third quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after acquiring an additional 1,190 shares in the last quarter. Trust Co. of Vermont grew its stake in Kenvue by 50.9% in the third quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock valued at $39,000 after acquiring an additional 804 shares during the period. Finally, New England Capital Financial Advisors LLC increased its holdings in shares of Kenvue by 81.4% in the third quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock worth $42,000 after acquiring an additional 1,150 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

KVUE has been the subject of a number of research reports. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Bank of America lowered their price objective on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating for the company in a research report on Wednesday, October 8th. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 26th. Finally, Citigroup dropped their price target on Kenvue from $20.00 to $17.00 and set a “neutral” rating on the stock in a research note on Thursday, October 9th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and thirteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $19.90.

Kenvue Trading Up 1.2%

Shares of Kenvue stock opened at $17.41 on Monday. The stock has a market cap of $33.36 billion, a P/E ratio of 23.21 and a beta of 0.60. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17. The business’s 50 day moving average is $17.16 and its 200-day moving average is $17.99.

Kenvue (NYSE:KVUE) last issued its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The company had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same period in the prior year, the firm earned $0.28 EPS. Kenvue’s quarterly revenue was down 3.5% compared to the same quarter last year. Equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be issued a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, February 11th. This represents a $0.83 annualized dividend and a yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Insider Transactions at Kenvue

In related news, Director Jeffrey C. Smith acquired 3,200,000 shares of Kenvue stock in a transaction on Friday, December 12th. The stock was purchased at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares in the company, valued at $474,333,567.84. This trade represents a 13.27% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.68% of the stock is owned by corporate insiders.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.